Cell Line : LC-2-AD
Cellosaurus Index : CVCL_1373
Cellosaurus ID : LC-2-AD
GDSC1 Name
, GDSC2 Name
: LC-2-ad
CCLE Name
: LC2AD_LUNG
Cancer Type : lung
Dataset : All
Drug Response Information
Click to show/hide information cards below or download all drug response information.
Information cards below will change according to the dataset selected. The default dataset is “All”, which means information in the cards is based on the integration. If “All” is not selected, information cards will contain drug response information preprocessed for each dataset independently.
Experimental information
Experimental information from All dataset, including cell line name, drug name, and minimum and maximum dosages used in each experiment. Click on Dose-response to query more detail for each experiment.
| Cellosaurus ID | Drug Name | Original Dataset(s) | Min Dose | Max Dose | Dose-response |
|---|---|---|---|---|---|
| LC-2-AD | (5Z)-7-Oxozeaenol | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | 5-Fluorouracil | GDSC1,GDSC2 | 0.0200 | 32.0000 |
|
| LC-2-AD | 965-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | 993-D2 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | A-443654 | GDSC1 | 0.0040 | 1.0240 |
|
| LC-2-AD | A-770041 | GDSC1 | 0.0200 | 5.1200 |
|
| LC-2-AD | A-83-01 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | ABT737 | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | ACY-1215 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | Afatinib | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| LC-2-AD | Afuresertib | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | AGI-5198 | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | AGI-6780 | GDSC1,GDSC2 | 0.0020 | 10.0000 |
|
| LC-2-AD | AGK-2 | GDSC2 | 0.0040 | 4.0000 |
|
| LC-2-AD | AICA Ribonucleotide | GDSC1 | 7.8125 | 2000.0000 |
|
| LC-2-AD | AKT inhibitor VIII | GDSC1 | 0.0100 | 10.2400 |
|
| LC-2-AD | Alectinib | GDSC1 | 0.0200 | 5.1200 |
|
| LC-2-AD | Alisertib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Alpelisib | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | AMG-319 | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Amuvatinib | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | Apitolisib | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | AR-42 | GDSC1 | 0.0200 | 5.1200 |
|
| LC-2-AD | Ara-G | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | ARRY-520 | GDSC1 | 0.0010 | 0.2560 |
|
| LC-2-AD | AS601245 | GDSC1 | 0.0312 | 8.0000 |
|
| LC-2-AD | AS605240 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | AST-1306 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | AT-7519 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | AT13148 | GDSC2 | 0.0080 | 8.0000 |
|
| LC-2-AD | AT7867 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | Avagacestat | GDSC1,GDSC2 | 0.0100 | 10.2400 |
|
| LC-2-AD | Axitinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LC-2-AD | AZ20 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | AZ6102 | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | AZ628 | GDSC1 | 0.0156 | 4.0000 |
|
| LC-2-AD | AZ960 | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | AZD1208 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | AZD1332 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | AZD1480 | GDSC1 | 0.0098 | 2.5000 |
|
| LC-2-AD | AZD2014 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | AZD3514 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | AZD3759 | GDSC2 | 0.0010 | 1.0000 |
|
| LC-2-AD | AZD4547 | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| LC-2-AD | AZD4877 | GDSC1 | 0.0002 | 0.0390 |
|
| LC-2-AD | AZD5363 | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | AZD5438 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | AZD5582 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | AZD6094 | GDSC1 | 0.0098 | 2.5000 |
|
| LC-2-AD | AZD6482 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | AZD6738 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | AZD7762 | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| LC-2-AD | AZD7969 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | AZD8055 | GDSC1 | 0.0078 | 2.0000 |
|
| LC-2-AD | AZD8186 | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| LC-2-AD | AZD8835 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | AZD8931 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | BAM7 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | BAY ACCi | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | BAY AKT1 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | BAY-61-3606 | GDSC1 | 0.0312 | 8.0000 |
|
| LC-2-AD | BAY-HDAC11_1 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | BAY-HDAC11_2 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | BAY-HDAC11_4 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | BAY-MPS-combo 2 (paclitaxel 1 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| LC-2-AD | BAY-MPS-combo-1 (paclitaxel 5 uM) | GDSC1 | 0.0039 | 1.0000 |
|
| LC-2-AD | BAY-MPS1 | GDSC1 | 0.0117 | 3.0000 |
|
| LC-2-AD | Belinostat | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | Bexarotene | GDSC1 | 0.0312 | 8.0000 |
|
| LC-2-AD | BI-2536 | GDSC1,GDSC2 | 0.0005 | 0.5000 |
|
| LC-2-AD | BIBF-1120 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | BIBR-1532 | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Bicalutamide | GDSC1,GDSC2 | 0.0040 | 10.0000 |
|
| LC-2-AD | BIX02189 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | Bleomycin | GDSC1 | 0.2500 | 64.0000 |
|
| LC-2-AD | Bleomycin (10 uM) | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | Bleomycin (50 uM) | GDSC1 | 0.1953 | 50.0000 |
|
| LC-2-AD | BMS-345541 | GDSC1,GDSC2 | 0.0100 | 16.0000 |
|
| LC-2-AD | BMS-509744 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | BMS-536924 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | BMS-754807 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Bortezomib | GDSC1,GDSC2 | 0.0000 | 0.0200 |
|
| LC-2-AD | Bosutinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| LC-2-AD | BPTES | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | Brivanib, BMS-540215 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | Bryostatin 1 | GDSC1 | 0.0000 | 0.0080 |
|
| LC-2-AD | Buparlisib | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | BX-912 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | BX795 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | C-75 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | Cabozantinib | GDSC1 | 0.0200 | 5.1200 |
|
| LC-2-AD | Camptothecin | GDSC2 | 0.0001 | 0.1000 |
|
| LC-2-AD | CAP-232, TT-232, TLN-232 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | Capivasertib | GDSC1 | 0.1172 | 30.0000 |
|
| LC-2-AD | CAY10566 | GDSC1 | 0.0100 | 2.5600 |
|
| LC-2-AD | CAY10603 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | CCT-018159 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | CCT007093 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | CCT245232 | GDSC1 | 0.0008 | 0.2000 |
|
| LC-2-AD | CCT245467 | GDSC1 | 0.0008 | 0.2000 |
|
| LC-2-AD | CD532 | GDSC1 | 0.0200 | 5.1200 |
|
| LC-2-AD | Cediranib | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Cetuximab | GDSC1 | 0.2570 | 65.8000 |
|
| LC-2-AD | CGP-082996 | GDSC1 | 0.0200 | 5.1200 |
|
| LC-2-AD | CGP-60474 | GDSC1 | 0.0010 | 0.2560 |
|
| LC-2-AD | CHIR-99021 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | CI-1033 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | CI-1040 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | Cisplatin | GDSC1 | 0.0117 | 10.0000 |
|
| LC-2-AD | CMK | GDSC1 | 0.0156 | 4.0000 |
|
| LC-2-AD | CP466722 | GDSC1 | 0.0625 | 16.0000 |
|
| LC-2-AD | CP724714 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | CPI-613 | GDSC1 | 1.0000 | 256.0000 |
|
| LC-2-AD | Crizotinib | GDSC1,GDSC2 | 0.0040 | 8.0000 |
|
| LC-2-AD | CRT0105446 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | CRT0105950 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | CRT0160829 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | CUDC-101 | GDSC1 | 0.0200 | 5.1200 |
|
| LC-2-AD | CX-5461 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | Cyclopamine | GDSC1 | 0.0625 | 16.0000 |
|
| LC-2-AD | Cyclophosphamide | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Cytarabine | GDSC1 | 0.0078 | 2.0000 |
|
| LC-2-AD | CZC24832 | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Dabrafenib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Dacinostat | GDSC1 | 0.0040 | 1.0240 |
|
| LC-2-AD | Dactinomycin | GDSC2 | 0.0008 | 0.8000 |
|
| LC-2-AD | Dactolisib | GDSC1,GDSC2 | 0.0003 | 2.0000 |
|
| LC-2-AD | Daporinad | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| LC-2-AD | Dasatinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| LC-2-AD | Dinaciclib | GDSC2 | 0.0010 | 1.0000 |
|
| LC-2-AD | DMOG | GDSC1 | 15.6250 | 4000.0000 |
|
| LC-2-AD | Docetaxel | GDSC1,GDSC2 | 0.0000 | 0.0125 |
|
| LC-2-AD | Doramapimod | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Doxorubicin | GDSC1 | 0.0040 | 5.0000 |
|
| LC-2-AD | Dyrk1b_0191 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | eEF2K Inhibitor, A-484954 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | EHT-1864 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Elesclomol | GDSC1,GDSC2 | 0.0002 | 0.2000 |
|
| LC-2-AD | Embelin | GDSC1 | 0.1250 | 32.0000 |
|
| LC-2-AD | Entinostat | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Entospletinib | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Enzastaurin | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | EphB4_9721 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | Epirubicin | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Epothilone B | GDSC1 | 0.0001 | 0.0320 |
|
| LC-2-AD | EPZ004777 | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | EPZ5676 | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Erlotinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LC-2-AD | Etoposide | GDSC1 | 0.0625 | 16.0000 |
|
| LC-2-AD | ETP-45835 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | Fedratinib | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | FEN1_3940 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | FGFR_0939 | GDSC1 | 0.0098 | 2.5000 |
|
| LC-2-AD | FGFR_3831 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | FH535 | GDSC1 | 0.1250 | 32.0000 |
|
| LC-2-AD | Flavopiridol | GDSC1 | 0.0100 | 2.5600 |
|
| LC-2-AD | FMK | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | Foretinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | FR-180204 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | FS106 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | FS112 | GDSC1 | 0.0195 | 5.0000 |
|
| LC-2-AD | FTI-277 | GDSC1 | 0.0040 | 1.0240 |
|
| LC-2-AD | FTY-720 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | Fulvestrant | GDSC1,GDSC2 | 0.0010 | 10.0000 |
|
| LC-2-AD | FY012 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | FY026 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | FY069 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | GDC0810 | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Gefitinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| LC-2-AD | Gemcitabine | GDSC1,GDSC2 | 0.0002 | 10.0000 |
|
| LC-2-AD | Genentech Cpd 10 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | GNE-317 | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | GNF-2 | GDSC1 | 0.0050 | 1.2800 |
|
| LC-2-AD | GSK-J4 | GDSC1 | 0.1172 | 30.0000 |
|
| LC-2-AD | GSK1059615 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | GSK1070916 | GDSC1 | 0.0100 | 2.5600 |
|
| LC-2-AD | GSK1904529A | GDSC1,GDSC2 | 0.0040 | 5.0000 |
|
| LC-2-AD | GSK2578215A | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | GSK2606414 | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | GSK269962A | GDSC1,GDSC2 | 0.0098 | 10.0000 |
|
| LC-2-AD | GSK319347A | GDSC1 | 0.0195 | 5.0000 |
|
| LC-2-AD | GSK343 | GDSC2 | 0.0010 | 1.0000 |
|
| LC-2-AD | GSK429286A | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | GSK591 | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | GSK650394 | GDSC1 | 0.0625 | 16.0000 |
|
| LC-2-AD | GSK690693 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | GW-2580 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | GW441756 | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| LC-2-AD | GW843682X | GDSC1 | 0.0010 | 0.2560 |
|
| LC-2-AD | HG6-64-1 | GDSC1 | 0.0200 | 5.1200 |
|
| LC-2-AD | I-BET-762 | GDSC1,GDSC2 | 0.0100 | 20.0000 |
|
| LC-2-AD | I-BET151 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | I-BRD9 | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | I-CBP112 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | IAP_5620 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | IAP_7638 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | Ibrutinib | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | IC-87114 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | ICL1100013 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | Idelalisib | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | IGFR_3801 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | Imatinib | GDSC1 | 0.0078 | 2.0000 |
|
| LC-2-AD | IMD-0354 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | IOX2 | GDSC1,GDSC2 | 0.0004 | 0.5000 |
|
| LC-2-AD | IPA-3 | GDSC1 | 0.1250 | 32.0000 |
|
| LC-2-AD | Ipatasertib | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Irinotecan | GDSC2 | 0.0050 | 5.0000 |
|
| LC-2-AD | Ispinesib Mesylate | GDSC1 | 0.0005 | 0.1280 |
|
| LC-2-AD | IWP-2 | GDSC2 | 0.0010 | 1.0000 |
|
| LC-2-AD | JAK1_3715 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | JAK3_7406 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | JNJ38877605 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | JNK Inhibitor VIII | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | JNK-9L | GDSC1 | 0.0200 | 5.1200 |
|
| LC-2-AD | JQ1 | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| LC-2-AD | JQ12 | GDSC1 | 0.0200 | 5.1200 |
|
| LC-2-AD | JW-7-24-1 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | JW-7-52-1 | GDSC1 | 0.0047 | 1.2000 |
|
| LC-2-AD | kb NB 142-70 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | KIN001-042 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | KIN001-236 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | KIN001-244 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | KIN001-260 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | KIN001-266 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | KIN001-270 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | Kobe2602 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | KRAS (G12C) Inhibitor-12 | GDSC2 | 0.0200 | 20.0000 |
|
| LC-2-AD | KU-55933 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | KU-60019 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | Lapatinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LC-2-AD | LCL161 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | LDN-193189 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | Leflunomide | GDSC2 | 0.1001 | 100.0000 |
|
| LC-2-AD | Lenalidomide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Lestaurtinib | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| LC-2-AD | LFM-A13 | GDSC1 | 0.0625 | 16.0000 |
|
| LC-2-AD | LGK974 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | LIMK1 inhibitor BMS4 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | Linifanib | GDSC1 | 0.0040 | 1.0240 |
|
| LC-2-AD | Linsitinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | LJI308 | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Luminespib | GDSC1,GDSC2 | 0.0003 | 0.2560 |
|
| LC-2-AD | LY2109761 | GDSC2 | 0.0050 | 5.0000 |
|
| LC-2-AD | Masitinib | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | MCT1_6447 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | MCT4_1422 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | MetAP2 Inhibitor, A832234 | GDSC1 | 0.0100 | 2.5600 |
|
| LC-2-AD | Methotrexate | GDSC1,GDSC2 | 0.0008 | 1.0000 |
|
| LC-2-AD | MG-132 | GDSC1,GDSC2 | 0.0039 | 4.0000 |
|
| LC-2-AD | Midostaurin | GDSC1 | 0.0020 | 0.5120 |
|
| LC-2-AD | MIM1 | GDSC1 | 0.1562 | 40.0000 |
|
| LC-2-AD | MIRA-1 | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Mirin | GDSC1,GDSC2 | 0.1001 | 100.0000 |
|
| LC-2-AD | Mitomycin-C | GDSC1 | 0.0625 | 16.0000 |
|
| LC-2-AD | MK-1775 | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | MK-2206 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LC-2-AD | MK-8776 | GDSC2 | 0.0050 | 5.0000 |
|
| LC-2-AD | ML323 | GDSC2 | 0.0200 | 20.0000 |
|
| LC-2-AD | MN-64 | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Motesanib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LC-2-AD | MPS-1-IN-1 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | N22899-6-C1 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | N23918-95-7 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | N24798-49-A1 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | Navitoclax | GDSC1,GDSC2 | 0.0020 | 2.0000 |
|
| LC-2-AD | NG-25 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | Nilotinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LC-2-AD | Niraparib | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | NPK76-II-72-1 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | NSC-207895 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | NSC-87877 | GDSC1 | 0.0625 | 16.0000 |
|
| LC-2-AD | NSC319726 | GDSC1 | 0.0010 | 0.2560 |
|
| LC-2-AD | NU7441 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LC-2-AD | Nutlin-3a | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | NVP-ADW742 | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | NVP-BHG712 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | NVP-TAE684 | GDSC1 | 0.0078 | 2.0000 |
|
| LC-2-AD | Obatoclax Mesylate | GDSC1 | 0.0625 | 16.0000 |
|
| LC-2-AD | OF-1 | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Olaparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Omipalisib | GDSC1 | 0.0005 | 0.1280 |
|
| LC-2-AD | OSI-027 | GDSC1,GDSC2 | 0.0100 | 20.0000 |
|
| LC-2-AD | OSI-930 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | Osimertinib | GDSC2 | 0.0010 | 1.0000 |
|
| LC-2-AD | OSU-03012 | GDSC1 | 0.0625 | 16.0000 |
|
| LC-2-AD | OTX015 | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Oxaliplatin | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | P22077 | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | PAC-1 | GDSC1 | 0.0100 | 2.5600 |
|
| LC-2-AD | Paclitaxel | GDSC1,GDSC2 | 0.0001 | 0.1024 |
|
| LC-2-AD | Palbociclib | GDSC1,GDSC2 | 0.0040 | 4.0000 |
|
| LC-2-AD | Panobinostat | GDSC1 | 0.0040 | 1.0240 |
|
| LC-2-AD | PARP_0108 | GDSC1 | 0.0098 | 2.5000 |
|
| LC-2-AD | PARP_9482 | GDSC1 | 0.0098 | 2.5000 |
|
| LC-2-AD | PARP_9495 | GDSC1 | 0.0098 | 2.5000 |
|
| LC-2-AD | Parthenolide | GDSC1 | 0.0195 | 5.0000 |
|
| LC-2-AD | Pazopanib | GDSC1 | 0.0312 | 8.0000 |
|
| LC-2-AD | PCI-34051 | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | PD0325901 | GDSC1,GDSC2 | 0.0010 | 2.5000 |
|
| LC-2-AD | PD173074 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LC-2-AD | Pelitinib | GDSC1 | 0.0098 | 2.5000 |
|
| LC-2-AD | Pemetrexed | GDSC1 | 0.0100 | 2.5600 |
|
| LC-2-AD | Pevonedistat | GDSC1,GDSC2 | 0.0039 | 10.0000 |
|
| LC-2-AD | PF-00299804 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | PF-4708671 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | PF-562271 | GDSC1 | 0.0100 | 2.5600 |
|
| LC-2-AD | PFI-1 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | PFI3 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | PHA-665752 | GDSC1 | 0.0078 | 2.0000 |
|
| LC-2-AD | PHA-793887 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | Phenformin | GDSC1 | 15.6250 | 4000.0000 |
|
| LC-2-AD | PI-103 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | PI3Ka_4409 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | Picolinici-acid | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Pictilisib | GDSC1,GDSC2 | 0.0040 | 4.0000 |
|
| LC-2-AD | PIK-93 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | Pilaralisib | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | Piperlongumine | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | PLK_6522 | GDSC1 | 0.0024 | 0.6250 |
|
| LC-2-AD | PLX-4720 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Ponatinib | GDSC1 | 0.0020 | 0.5120 |
|
| LC-2-AD | PRIMA-1MET | GDSC2 | 0.0300 | 30.0000 |
|
| LC-2-AD | PRT062607 | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Pyridostatin | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Pyrimethamine | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | QL-X-138 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | QL-XI-92 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | QL-XII-47 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | QS11 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | Quizartinib | GDSC1 | 0.0040 | 1.0240 |
|
| LC-2-AD | RAF_9304 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | Rapamycin | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| LC-2-AD | Refametinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Ribociclib | GDSC2 | 0.0020 | 2.0000 |
|
| LC-2-AD | RO-3306 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | rTRAIL | GDSC1 | 0.0004 | 0.1000 |
|
| LC-2-AD | RU-SKI 43 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | Rucaparib | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| LC-2-AD | Ruxolitinib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | RVX-208 | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | S-Trityl-L-cysteine | GDSC1 | 0.0200 | 5.1200 |
|
| LC-2-AD | Sabutoclax | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Salubrinal | GDSC1 | 0.0625 | 16.0000 |
|
| LC-2-AD | Sapitinib | GDSC2 | 0.0050 | 5.0000 |
|
| LC-2-AD | Saracatinib | GDSC1 | 0.0078 | 2.0000 |
|
| LC-2-AD | Savolitinib | GDSC2 | 0.0010 | 1.0000 |
|
| LC-2-AD | SB216763 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | SB505124 | GDSC1,GDSC2 | 0.0100 | 20.0000 |
|
| LC-2-AD | SB52334 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | SB590885 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| LC-2-AD | SCH772984 | GDSC2 | 0.0050 | 5.0000 |
|
| LC-2-AD | Seliciclib | GDSC1 | 0.0625 | 16.0000 |
|
| LC-2-AD | Selisistat | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | Selumetinib | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LC-2-AD | Sepantronium bromide | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Serdemetan | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | SGC0946 | GDSC1,GDSC2 | 0.0005 | 0.5000 |
|
| LC-2-AD | Shikonin | GDSC1 | 0.0625 | 16.0000 |
|
| LC-2-AD | SL0101 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | SN-38 | GDSC1,GDSC2 | 0.0002 | 10.0000 |
|
| LC-2-AD | SNX-2112 | GDSC1 | 0.0100 | 2.5600 |
|
| LC-2-AD | Sorafenib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Sphingosine Kinase 1 Inhibitor II | GDSC1 | 0.0100 | 2.5600 |
|
| LC-2-AD | Staurosporine | GDSC2 | 0.0078 | 2.0000 |
|
| LC-2-AD | STF-62247 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | SU11274 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | Sunitinib | GDSC1 | 0.0312 | 8.0000 |
|
| LC-2-AD | T0901317 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | TAK-715 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | Talazoparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Tamoxifen | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Tanespimycin | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| LC-2-AD | TANK_1366 | GDSC1 | 0.0098 | 2.5000 |
|
| LC-2-AD | Taselisib | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Telomerase Inhibitor IX | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Temozolomide | GDSC1,GDSC2 | 0.0300 | 30.0000 |
|
| LC-2-AD | Temsirolimus | GDSC1,GDSC2 | 0.0008 | 1.0000 |
|
| LC-2-AD | Tenovin-6 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | TGX221 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | Thapsigargin | GDSC1 | 0.0020 | 0.5120 |
|
| LC-2-AD | THZ-2-102-1 | GDSC1 | 0.0098 | 2.5000 |
|
| LC-2-AD | THZ-2-49 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | Tipifarnib | GDSC1 | 0.0625 | 16.0000 |
|
| LC-2-AD | Tivozanib | GDSC1 | 0.0005 | 0.1280 |
|
| LC-2-AD | TL-1-85 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | TL-2-105 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | Torin 2 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | Tozasertib | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| LC-2-AD | TPCA-1 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | Trametinib | GDSC1,GDSC2 | 0.0010 | 1.0000 |
|
| LC-2-AD | Tretinoin | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Trichostatin A | GDSC1 | 0.0040 | 1.0240 |
|
| LC-2-AD | TTK_3146 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | Tubastatin A | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | TW 37 | GDSC1 | 0.0195 | 5.0000 |
|
| LC-2-AD | TWS119 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | Ulixertinib | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | UNC0638 | GDSC1 | 0.0781 | 40.0000 |
|
| LC-2-AD | UNC0642 | GDSC1 | 0.0020 | 0.5000 |
|
| LC-2-AD | UNC1215 | GDSC1 | 0.0039 | 1.0000 |
|
| LC-2-AD | Uprosertib | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | VE-822 | GDSC2 | 0.0050 | 5.0000 |
|
| LC-2-AD | VE821 | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Veliparib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Venetoclax | GDSC2 | 0.0010 | 1.0000 |
|
| LC-2-AD | Venotoclax | GDSC1 | 0.0010 | 0.2560 |
|
| LC-2-AD | Vinblastine | GDSC1 | 0.0004 | 0.1000 |
|
| LC-2-AD | Vinorelbine | GDSC1,GDSC2 | 0.0001 | 0.1000 |
|
| LC-2-AD | Vismodegib | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | VNLG-124 | GDSC1 | 0.0200 | 5.1200 |
|
| LC-2-AD | Vorinostat | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Voxtalisib | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | VX-11e | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | VX-702 | GDSC1 | 0.0078 | 2.0000 |
|
| LC-2-AD | Wee1 Inhibitor | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LC-2-AD | WEHI-539 | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | WH-4-023 | GDSC1 | 0.0200 | 5.1200 |
|
| LC-2-AD | WHI-P97 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | WIKI4 | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | Wnt-C59 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | WYE-125132 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | WZ-1-84 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | WZ3105 | GDSC1 | 0.0050 | 1.2800 |
|
| LC-2-AD | WZ4003 | GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | XAV939 | GDSC1,GDSC2 | 0.0050 | 5.0000 |
|
| LC-2-AD | XMD13-2 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | XMD14-99 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | XMD15-27 | GDSC1 | 0.0400 | 10.2400 |
|
| LC-2-AD | XMD8-85 | GDSC1 | 0.0312 | 8.0000 |
|
| LC-2-AD | Y-39983 | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | YK-4-279 | GDSC1,GDSC2 | 0.0100 | 10.0000 |
|
| LC-2-AD | YM201636 | GDSC1 | 0.0200 | 5.1200 |
|
| LC-2-AD | Z-LLNle-CHO | GDSC1 | 0.0100 | 2.5600 |
|
| LC-2-AD | Zibotentan | GDSC1 | 0.0781 | 20.0000 |
|
| LC-2-AD | ZL049 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | ZL109 | GDSC1 | 0.0391 | 10.0000 |
|
| LC-2-AD | ZM447439 | GDSC1,GDSC2 | 0.0078 | 10.0000 |
|
| LC-2-AD | ZSTK474 | GDSC1 | 0.0200 | 5.1200 |
|
IC50
IC50 indicates how much drug dosage is needed to inhibit the cells by 50%, in vitro, compared to the control well.
Drugs with highest and lowest IC50
Drugs with highest and lowest IC50
IC90
IC90 indicates how much drug dosage is needed to inhibit the cells by 90%, in vitro, compared to the control well.
Drugs with highest and lowest IC90
Drugs with highest and lowest IC90
AUC
AUC represents the area under a dose-response curve, where 0% indicates no activity and 100% indicates that a drug completely inhibits the cells across testing dosages.
Drugs with highest and lowest AUC
Drugs with highest and lowest AUC